| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:GENOTIPIZACIJA VKORC1, CYP4F2, CYP2C9 NA VZORCU SPLOŠNE POPULACIJE
Authors:ID Mihalič, Lea (Author)
ID Glaser, Marjana (Mentor) More about this mentor... New window
ID Stangler Herodež, Špela (Comentor)
Files:.pdf UNI_Mihalic_Lea_2012.pdf (1,59 MB)
MD5: 796594B255A0E186D03D6FE42B4BF11B
PID: 20.500.12556/dkum/88bd8d18-8c64-4672-b464-dad564e38b5d
 
Language:Slovenian
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FKKT - Faculty of Chemistry and Chemical Engineering
Abstract:Namen diplomske naloge je določiti genotipe specifičnih enonukleotidnih polimorfizmov tarčnih genov, ki so odgovorni za višji ali nižji začetni odmerek varfarina. To so VKORC1-1639G>A, CYP2C92-430C>T, CYP2C93-1075A>C, CYP4F2-132C>T. Varfarin je učinkovina, oralni antikoagulant, ki se predpisuje bolnikom z pljučno embolijo, globoko vensko trombozo, tromboembolijo. Varfarinska terapija zahteva veliki nadzor nad pravilnim odmerkom varfarina, zdravljenje je dolgotrajno in ima neželene stranske učinke kot so krvavitve. Na optimalni odmerek varfarina v kar 40% vplivajo genetski dejavniki, zato je smiselna genotipizacija omenjenih tarčnih genov. Uporabili smo alelno specifično verižno reakcijo s polimerazo in nato gelsko elektroforezo. Metoda je hitra, enostavna, ekonomsko učinkovita.Rezultati diplomske naloge kažejo, da je 87% ljudi takšnih pri katerih lahko pričakujemo po zauzetju normalnega odmerka varfarina pretiran odziv.
Keywords:alelno specifična verižna reakcija s polimerazo, VKORC1, CYP29, CYP4F2, SNP, varfarin, vitamin K
Place of publishing:Maribor
Publisher:[L. Mihalič]
Year of publishing:2012
PID:20.500.12556/DKUM-36832 New window
UDC:577.112.38+575.17(043.2)
COBISS.SI-ID:4436031 New window
NUK URN:URN:SI:UM:DK:D4ISSV8J
Publication date in DKUM:17.07.2012
Views:3155
Downloads:283
Metadata:XML DC-XML DC-RDF
Categories:KTFMB - FKKT
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:English
Title:VKORC1, CYP4F2, CYP2C9 GENOTYPING ON A SAMPLE OF THE GENERAL POPULATION
Abstract:The purpose of this thesis is to determine the genotypes of specific nucleotide polymorphisms target genes that are responsible for higher or lower initiating dose of warfarin. These are the VKORC1-1639G> A, CYP2C92-430C> T, CYP2C93-1075> C, CYP4F2-132C> T. Warfarin is the active ingredient, oral anticoagulant, which is prescribed to patients with pulmonary embolism, deep venous thrombosis, thromboembolism. Warfarin therapy requires great control of the correct dose of warfarin, treatment is long and has side effects such as bleeding. At the optimal dose of warfarin in 40% affected by genetic factors, so it makes sense genotyping of these target genes. We used allele-specific PCR and then gel electrophoresis. The method is fast, simple, economic.Results show that 87% of these people are those, where we can expect after warfarin take excessive response
Keywords:allele-specific chain reaction with polymerase, SNP. VKORC!, CYP2C9, CYP4F2, warfarin, vitamine K


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica